Natural Capsules [NATCAPSUQ] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Natural Capsules

NSE
Loading...

Sun Pharma Advanced

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Natural Capsules wins in 12 metrics, Sun Pharma Advanced wins in 6 metrics, with 0 ties. Natural Capsules appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNatural CapsulesSun Pharma AdvancedBetter
P/E Ratio (TTM)337.98-13.68Sun Pharma Advanced
Price-to-Book Ratio0.84-21.57Sun Pharma Advanced
Debt-to-Equity Ratio40.91-1.24Sun Pharma Advanced
PEG Ratio-0.360.30Natural Capsules
EV/EBITDA28.51-17.40Sun Pharma Advanced
Profit Margin (TTM)-3.18%-53.22%Natural Capsules
Operating Margin (TTM)-8.61%-568.05%Natural Capsules
Return on Equity0.24%157.88%Sun Pharma Advanced
Return on Assets (TTM)0.15%-102.08%Natural Capsules
Free Cash Flow (TTM)$-178.78M$-3.71BNatural Capsules
1-Year Return-17.28%-34.13%Natural Capsules
Price-to-Sales Ratio (TTM)1.1472.37Natural Capsules
Enterprise Value$3.20B$49.34BSun Pharma Advanced
EV/Revenue Ratio1.8376.39Natural Capsules
Gross Profit Margin (TTM)47.85%-10.68%Natural Capsules
Revenue per Share (TTM)$174$2Natural Capsules
Earnings per Share (Diluted)$-5.42$-9.19Natural Capsules
Beta (Stock Volatility)-0.260.30Natural Capsules
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Natural Capsules vs Sun Pharma Advanced Stock Performance Analysis

Loading Price Chart...

Natural Capsules
Sun Pharma Advanced
Natural Capsules Stock Overview | Sun Pharma Advanced Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Natural Capsules9.06%9.44%1.83%-1.50%5.56%-17.28%
Sun Pharma Advanced-0.30%-0.46%0.18%-8.55%22.70%-28.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Natural Capsules-17.28%-17.28%-17.28%-17.28%-17.28%-17.28%
Sun Pharma Advanced-34.13%-33.75%-14.49%-62.56%59.18%-50.50%

News Based Sentiment: Natural Capsules vs Sun Pharma Advanced

Natural Capsules

News based Sentiment: NEGATIVE

The month was dominated by disappointing financial results, with a substantial decline in profitability and a shift to a net loss. While the valuation grade improved and leadership stability was maintained, the negative earnings and cautious investor sentiment outweigh these positives, making it a concerning month for investors.

View Natural Capsules News Sentiment Analysis

Sun Pharma Advanced

News based Sentiment: MIXED

September brought a surprising analyst upgrade to 'Buy' with a massive price target for SPARC, despite the company continuing to report losses and declining revenue. This creates a mixed investment picture, with potential upside balanced against significant risks, making it a noteworthy month for investors.

View Sun Pharma Advanced News Sentiment Analysis

Performance & Financial Health Analysis: Natural Capsules vs Sun Pharma Advanced

MetricNATCAPSUQSPARC
Market Information
Market Cap i₹1.98B₹46.74B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i10,122205,981
90 Day Avg. Volume i8,610222,297
Last Close₹206.42₹143.87
52 Week Range₹164.00 - ₹274.75₹109.30 - ₹241.00
% from 52W High-24.87%-40.30%
All-Time High₹274.75 (Jun 02, 2025)₹875.00 (Apr 24, 2006)
% from All-Time High-24.87%-83.56%
Growth Metrics
Quarterly Revenue Growth0.15%-0.43%
Quarterly Earnings Growth0.15%-0.43%
Financial Health
Profit Margin (TTM) i-0.03%-0.53%
Operating Margin (TTM) i-0.09%-5.68%
Return on Equity (TTM) i0.00%1.58%
Debt to Equity (MRQ) i40.91-1.24
Cash & Liquidity
Book Value per Share (MRQ)₹225.25₹-6.69
Cash per Share (MRQ)₹5.05₹0.06
Operating Cash Flow (TTM) i₹103.85M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹6.17M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Natural Capsules vs Sun Pharma Advanced

MetricNATCAPSUQSPARC
Price Ratios
P/E Ratio (TTM) i337.98-13.68
Forward P/E iN/A2.60
PEG Ratio i-0.360.30
Price to Sales (TTM) i1.1472.37
Price to Book (MRQ) i0.84-21.57
Market Capitalization
Market Capitalization i₹1.98B₹46.74B
Enterprise Value i₹3.20B₹49.34B
Enterprise Value Metrics
Enterprise to Revenue i1.8376.39
Enterprise to EBITDA i28.51-17.40
Risk & Other Metrics
Beta i-0.260.30
Book Value per Share (MRQ) i₹225.25₹-6.69

Financial Statements Comparison: Natural Capsules vs Sun Pharma Advanced

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NATCAPSUQSPARC
Revenue/Sales i₹452.03M₹96.40M
Cost of Goods Sold i₹235.74M₹106.70M
Gross Profit i₹216.29M₹-10.30M
Research & Development iN/AN/A
Operating Income (EBIT) i₹-38.93M₹-547.60M
EBITDA i₹6.78M₹-429.40M
Pre-Tax Income i₹-60.64M₹-518.10M
Income Tax i₹-4.84M₹600,000
Net Income (Profit) i₹-55.81M₹-518.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NATCAPSUQSPARC
Cash & Equivalents i₹6.63M₹19.64M
Total Current Assets i₹1.30B₹261.97M
Total Current Liabilities i₹999.93M₹3.74B
Long-Term Debt i₹574.25M₹1.07B
Total Shareholders Equity i₹2.57B₹-2.17B
Retained Earnings i₹794.95M₹-23.22B
Property, Plant & Equipment i₹31.20M₹178.02M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NATCAPSUQSPARC
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNATCAPSUQSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i10,122205,981
Average Daily Volume (90 Day) i8,610222,297
Shares Outstanding i10.35M324.52M
Float Shares i3.62M91.74M
% Held by Insiders i0.65%0.73%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Natural Capsules vs Sun Pharma Advanced

MetricNATCAPSUQSPARC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A